Article

Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma

2018-08-21

Abstract excerpt

<h4>ABSTRACT</h4> Cancer patients with advanced disease exhaust available clinical regimens and lack actionable genomic medicine results, leaving a large patient population without effective treatments options when their disease inevitably progresses. To address the unmet clinical need for evidence-based therapy assignment when standard clinical approaches have failed, we have developed a probabilistic computatio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0d4ba114-4d4d-5191-80e9-550decfbc3db
DOI: 10.1101/396358

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcomaDOI 10.1101/396358Read

The landscape of drug sensitivity and resistance in sarcomaSemantic proximity Read

Systematic pan-cancer analysis of mutation-treatment interactions using large real-world clinicogenomics data.Semantic proximity Read

Systematic functional drug testing in patient-derived models reveals ex vivo sensitivities associated with clinical outcome in rare solid tumorsSemantic proximity Read

Quantifying Treatment Resistance in Mixtures of Gastrointestinal Stromal Tumor Cells with BARMIXSemantic proximity Read

Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolutionSemantic proximity Read

Creation of MLPA: A Multi-level Digital Twin Framework for Personalized Cancer Simulation and Treatment OptimizationSemantic proximity Read

The landscape of drug sensitivity and resistance in sarcomaSemantic proximity Read

Integrated <i>ex vivo</i> screening and transcriptomic profiling to prioritize drug combinations for rare cancersSemantic proximity Read

Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures.Semantic proximity Read

Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistanceSemantic proximity Read

Probabilistic Learning of Treatment Trees in CancerSemantic proximity Read

Probabilistic graph-based model uncovers previously unseen druggable vulnerabilities in major solid cancersSemantic proximity Read